NCT06422585

Brief Summary

The goal of this observational study is to compare the equivalent analgesic efficacy of three regional anesthesia techniques in total knee replacement surgery. The main question it aims to answer is: • Non inferiority of each technique in relation to the others Participants will receive selective spinal anesthesia and the antalgic nerve block depending on the group they happen to be in. Researchers will compare the Femoral Nerve Group+IPACK block, the Saphenous Nerve block+IPACK and the Subsartorial Block groups to see if there is any difference in the pain control in the 24 hours after the surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

April 26, 2024

Last Update Submit

May 19, 2024

Conditions

Keywords

KneePost procedural painRegional anesthesia

Outcome Measures

Primary Outcomes (1)

  • NRS

    To compare the analgesic effect at 24 hours, of a nerve block technique compared to others after selective spinal anesthetic is administerd to achieve surgical anesthesia.Evaluate pain for every group in the first 24 hours post surgery using the Numeric Pain Scale (NRS) assigning a numeric value between zero (no pain) and ten (the worst pain ever felt). Absence of relevant pain is considered a NRS less than three. Success of the block was defined as NRS≤3.

    Baseline, every 6 hours for the first 24 hours after surgery

Secondary Outcomes (1)

  • side effect

    24 hours

Study Arms (3)

Femoral Nerve Block + IPACK Block

After adequate venous access has been obtained, spinal anesthesia with Levobupivacaine will be performed. After which antalgic Femoral Nerve Block and IPACK Block will be performed.

Saphenous (Adductor Canal) Block + IPACK Block

After adequate venous access has been obtained, spinal anesthesia with Levobupivacaine will be performed. After which Saphenous and IPACK Block will be performed.

Dual Subsartorial Block

After adequate venous access has been obtained, spinal anesthesia with Levobupivacaine will be performed. After which Dual Subsartorial Block will be performed.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients meeting the inclusion criteria

You may qualify if:

  • Age \> 18 y/o
  • Total knee replacement elective surgery
  • Informed consent

You may not qualify if:

  • Age \< 18 y/o
  • Surgery with general anesthesia
  • Patients with coagulopaties
  • Patients in chronic opioid therapy
  • Refuse to sign informed consent form
  • Unable to sign informed consent form
  • Know allergies to medication used for analgesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edificio 3 - Azienda Ospedaliero Universitaria Pisana Cisanello

Pisa, Tuscany, 56124, Italy

RECRUITING

MeSH Terms

Conditions

Pain, Procedural

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Silvia Nardi, MD

    Azienda Ospedaliera Universitaria Pisana

    STUDY DIRECTOR
  • Alessandro Cardu, MD

    Scuola Specializzazione - Università di Pisa

    STUDY CHAIR

Central Study Contacts

Serena Ricalzone, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 21, 2024

Study Start

February 1, 2024

Primary Completion

February 1, 2025

Study Completion

February 1, 2025

Last Updated

May 21, 2024

Record last verified: 2024-05

Locations